PHARMACEUTICAL COMPOSITION ADAPTED FOR ORAL ADMINISTRATION AND METHOD OF ITS PRODUCTION FOR PREVENTION AND TREATMENT OF AN IRRITATED INTESTINAL BASIS ON THE BASIS OF THE GICHELEZIDES DIESEL-IZELEZERO-DIATER-DYNAMIC DIODER

摘要

1. A pharmaceutical composition intended for administration orally in the form of a tablet, coated tablet, capsule or soluble powder for intestinal disorders, based on an intestinal motility modifier and an α-D-galactosidase enzyme, the composition consists mainly of an intestinal motility modifier and an α-D enzyme β-galactosidase, a binder, a diluent, a lubricant, a glidant, and a disintegrant or suspending agent. 2. The pharmaceutical composition according to claim 1, wherein the intestinal motility modifier may be trimebutine, phenoverine, mebeverin, dicycloverin, pinaverium bromide, alosetron, tegaserod, loperamide, fluroglucin, trimethylfluroglucin, butylscopolamine, parveverin. 3. The pharmaceutical composition of claim 2, wherein the intestinal motility modifier may be trimebutin and its pharmaceutically acceptable salts. The pharmaceutical composition of claim 2, wherein the intestinal motility modifier may be phenovenine and pharmaceutically acceptable salts thereof. The pharmaceutical composition of claim 2, wherein the intestinal motility modifier may be mebeverin and its pharmaceutically acceptable salts. The pharmaceutical composition according to claim 2, wherein the intestinal motility modifier may be dicycloverin and its pharmaceutically acceptable salts. The pharmaceutical composition of claim 2, wherein the intestinal motility modifier may be pinaverium bromide and pharmaceutically acceptable salts thereof. The pharmaceutical composition of claim 2, wherein the intestinal motility modifier may be alosetron and its pharmaceutically acceptable salts. Headlight